Building an Australian Medical Countermeasure Capability
https://www.certara.com/article/building-an-australian-medical-countermeasure-capability/
3 results
Essentials of Model-informed Drug Development (MIDD) – Top-down vs. Bottom-up Approaches
How can the latest modeling and simulation technologies accelerate drug discovery and development? We frequently receive questions about why model-informed drug development (MIDD) is so critical to informing the development of safer and more effective new drugs? Indeed, all drug discovery and development today involves some level of MIDD, a term that encompasses a large … Continued
https://www.certara.com/blog/essentials-of-model-informed-drug-development-midd-top-down-vs-bottom-up-approaches/Certara Announces New Clinical Science Group and Adds Senior Scientific Experts
Multi-Disciplinary Expansion and New Appointments Grow Capacity and Capabilities PRINCETON, N.J.— September 22, 2021. Certara, a global leader in biosimulation, today announced that it is expanding its Integrated Drug Development (IDD) division with a new clinical science group, headed up by Philippa Marshall, M.D., Vice President of Clinical Science. The Company also appointed David Mitchell, … Continued
https://www.certara.com/pressrelease/certara-announces-new-clinical-science-group-and-adds-senior-scientific-experts/
1 of
1
